Search

Astellas Pharma Inc.
  • Top MenuAbout
    • Philosophy
    • Vision & Strategy
    • Group Code of Conduct
    • Astellas Pharma Israel
    • Policies & Position Statements
    • Ethics & Compliance
    • Transparency
    • Making an Impact
    • Support for Medical Education
  • Top MenuTherapy Areas
    • Therapy Areas
      • Urology
      • Oncology / Haematology
      • Transplantation
      • Women’s Health
    • Astellas Products
      • BETMIGA™ (mirabegron)
      • XTANDI™ (enzalutamide)
      • XOSPATA™ (gilteritinib)
      • ADVAGRAF™ (tacrolimus prolonged release)
      • PROGRAF™ (tacrolimus)
      • PADCEV™ (enfortumab vedotin)
      • VEOZA™ (fezolinetant)
  • Top MenuInnovation
    Clinical Trials
    Astellas has established a website to disclose information obtained from Astellas-sponsored clinical trials…
    לקריאה נוספת
    • R & D
      • Clinical Trials
      • Approach
      • Ethics & Principles
    • Pipeline
    • Investigator Sponsored Research
  • Top MenuSustainability
    Access to Health
    Advances continue to be made in technology and medicine that address unmet medical needs. However, there still remain barriers for many people…
    לקריאה נוספת
    • Global Sustainability Policy
    • Sustainability Approach
    • Access to Health
    • Environment
    • Modern Slavery Act
    • Gender Pay Gap Report
  • Top MenuNews
    Media Contacts
    The Astellas Corporate Communications team will respond to calls and emails from journalists. For general media enquiries, please email contact_uk...
    לקריאה נוספת
    • News
    • Media Contacts
    • Social Media Code of Conduct

Common header menu

  • CONTACT US
  • CAREERS
  • WORLDWIDE
  • ISRAEL
  • WORLDWIDE - ISRAEL
  • English
  • עברית
  1. Home
  2. Therapy Areas

Therapy Areas

Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients worldwide.

Every day we work to address unmet medical needs with a prioritised focus on the following therapeutic areas:

Urology

We are leading the way in developing pioneering treatments for lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH), prostate cancer...

Oncology / Haematology

We are committed to the fight against cancer. We have a number of treatments for various cancers moving through clinical development, with many more...

Transplantation

Astellas Pharma is a major supporter of the transplantation community. We have made significant advances in immunosuppression, improving outcomes in...

Women’s Health

At Astellas we are dedicated to Women's Health, with a particular focus on supporting women in menopause, aiming to significantly enhance their...

  • Linkedin
  • Twitter

Therapy Areas

Main navigation

  • Therapy Areas
    • Urology
    • Oncology / Haematology
    • Transplantation
    • Women’s Health
  • Astellas Products
    • BETMIGA™ (mirabegron)
    • XTANDI™ (enzalutamide)
    • XOSPATA™ (gilteritinib)
    • ADVAGRAF™ (tacrolimus prolonged release)
    • PROGRAF™ (tacrolimus)
    • PADCEV™ (enfortumab vedotin)
    • VEOZA™ (fezolinetant)

MAT-IL-NON-2024-00011

LogoSolgan

Follow us on social media

linkedin_icon X logo-white-footer

Bottom footer menu

  • SITE MAP
  • PRIVACY NOTICE
  • TERMS OF USE
  • COOKIES POLICY
© 2024 Astellas Pharma Inc.

Update cookie preference